JNK (N-terminal c-Jun kinase) plays an important role in the growth of prostate carcinoma in vitro and in vivo, through the control of processes such as apoptosis, proliferation, migration, survival, differentiation, and inflammation via activation of several molecules. This evidence concerns the gene MAPK8 and prostate carcinoma.